Nektar Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Carlos CA United States (1990)

Organization Overview

First Clinical Trial
1999
NCT00370565
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nektar Therapeutics